Advanced Microbubbles
Latest round
- Seed
Last raised
- May 2020
Total raised
- Undisclosed
Investors
- 2
About Advanced Microbubbles
Advanced Microbubbles Inc develops innovative microbubble technologies for medical and industrial applications, enhancing drug delivery systems and imaging clarity.Advanced Microbubbles Inc, founded in 2014 in Newark, US, focuses on the development of advanced microbubble technologies. The company was established by Jameel Feshitan and Shashank Sirsi, with Jameel Feshitan currently serving as CEO.Advanced Microbubbles Inc. specializes in the development and production of innovative microbubble technologies designed to enhance various applications in the medical and industrial sectors. Their core offerings include advanced microbubble agents that facilitate improved drug delivery systems, particularly in ultrasound therapies. These microbubbles serve as contrast agents, enhancing imaging clarity while also enabling targeted therapeutic delivery to specific tissues, addressing challenges in precision medicine and diagnostics. The company's products are utilized in clinical settings and research environments, with a diverse client base that includes hospitals, research institutions, and pharmaceutical companies across North America and Europe.The revenue structure of Advanced Microbubbles Inc. is derived from B2B transactions involving direct sales of their microbubble products to healthcare providers and research institutions. Partnerships with hospitals and pharmaceutical companies are integral to their business model, enabling the establishment of long-term contracts for specialized microbubble agents. Transactions generally involve bulk purchasing agreements, where clients order products based on specific needs for medical applications, such as contrast-enhanced ultrasound imaging or targeted drug delivery. Advanced Microbubbles' flagship products are positioned within premium pricing tiers, reflecting their unique technological advancements and efficacy in clinical applications.Advanced Microbubbles Inc. plans to introduce new microbubble products aimed at improving drug delivery and diagnostic capabilities, with potential launches anticipated in the next two years. The company is targeting expansion into the European market, specifically in countries with growing healthcare infrastructure, by 2023.
Who invested in Advanced Microbubbles
2 investors across 1 round
See all investors in Advanced Microbubbles
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 14, 2020
Amount
Undisclosed
Investors
Questions about Advanced Microbubbles
Who invested in Advanced Microbubbles?
Advanced Microbubbles has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Advanced Microbubbles raised?
Advanced Microbubbles has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Advanced Microbubbles last raise money?
Advanced Microbubbles's most recent round on record is a Seed, in May 2020.
What does Advanced Microbubbles do?
Advanced Microbubbles Inc develops innovative microbubble technologies for medical and industrial applications, enhancing drug delivery systems and imaging clarity.
Where is Advanced Microbubbles headquartered?
Advanced Microbubbles is headquartered in Newark, US.
Which VCs invest in companies like Advanced Microbubbles?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Advanced Microbubbles's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Advanced Microbubbles? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.